2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$3.32+$0.02 (+0.48%)
Price as of Jul 14, 2026 6:14 AM EDT- $1.7BMarket Cap
- -37.50%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$3.32+$0.02 (+0.48%)
Earnings Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -10.32% | ||
12-Month Momentum | -42.42% | ||
3-Month Risk Adjusted Momentum | -34.26% | ||
12-Month Risk Adjusted Momentum | -62.32% |
True Yield
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.16% | ||
Net Debt Paydown Yield | 0.10% |
Financial Health Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |